A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique. On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at the West China Hospital, also in Chengdu.
This is really exciting as we've already seen CRISPR-enabled technology having exciting applications in animal testing (Example). This lab in China is the first to have carried out human trials of any form, and a US trial will start as early as 2017. As this article rightly noted, as soon as these trials become mainstream, there's going to be a huge boom in biomedical research and a lot more invested in this technology internationally.